Spero Therapeutics Free Cash Flow (FCF) History (SPRO)
Spero Therapeutics reported −$86.0M in free cash flow for fiscal 2020, a decrease of $35.7M from the previous fiscal year, with a free cash flow margin of −33344.57%.
View full Spero Therapeutics company overviewSpero Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2020 | 2020-12-31 | −$86.0M | −$35.7M | — | −33344.57% |
| 2019 | 2019-12-31 | −$50.3M | −$8.3M | — | −1061.45% |
| 2018 | 2018-12-31 | −$42.1M | −$2.9M | — | −1060.54% |
| 2017 | 2017-12-31 | −$39.1M | −$9.3M | — | −1977.67% |
| 2016 | 2016-12-31 | −$29.8M | −$19.9M | — | −8892.24% |
| 2015 | 2015-12-31 | −$9.8M | — | — | — |
Spero Therapeutics quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2021 | 2021-09-30 | −$5.0M | $16.4M | — | −699.44% |
| Q4 2020 | 2020-12-31 | −$16.4M | $1.1M | — | — |
| Q3 2020 | 2020-09-30 | −$21.3M | −$11.6M | — | −56092.11% |
| Q2 2020 | 2020-06-30 | −$24.9M | −$12.8M | — | −48845.10% |
| Q1 2020 | 2020-03-31 | −$23.4M | −$12.4M | — | −13850.89% |
| Q4 2019 | 2019-12-31 | −$17.5M | — | — | −2513.79% |
| Q3 2019 | 2019-09-30 | −$9.7M | — | — | −5625.58% |
| Q2 2019 | 2019-06-30 | −$12.2M | — | — | −18144.78% |
| Q1 2019 | 2019-03-31 | −$11.0M | — | — | −289.07% |
Spero Therapeutics free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$9.8M to −$86.0M, a net decrease of $76.2M. Spero Therapeutics's latest reported quarter, Q3 2021, generated −$5.0M in free cash flow, an increase of $16.4M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Spero Therapeutics source filings ↗